NICE: A nightmare worth having? Response

被引：3
作者：
Drummond, Michael [1 ]
机构：
[1] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
来源：
HEALTH ECONOMICS POLICY AND LAW | 2007年 / 2卷 / 02期
关键词：
D O I：
10.1017/S1744133107004033
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：203 / 208
页数：6
相关论文
共 5 条
[1]   Assessing the economic challenges posed by orphan drugs [J].
Drummond, Michael F. ;
Wilson, David A. ;
Kanavos, Panos ;
Ubel, Peter ;
Rovira, Joan .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) :36-42
[2]  
Sculpher MJ, 2004, HEALTH TECHNOL ASSES, V8, P1
[3]   What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews [J].
Sheldon, TA ;
Cullum, N ;
Dawson, D ;
Lankshear, A ;
Lowson, K ;
Watt, I ;
West, P ;
Wright, D ;
Wright, J .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7473) :999-1003
[4]   The failings of NICE - Time to start work on version 2 [J].
Smith, R .
BRITISH MEDICAL JOURNAL, 2000, 321 (7273) :1363-1364
[5]  
WILLIAMS A, 2004, HDB HLTH EC B, V1
1